4

FORM 4 SUBMISSION

Company: Viridian Therapeutics, Inc.\DE
Filed: March 3, 2022
Period of Report: March 1, 2022
Accession Number: 0000899243-22-009096

View Document ↗ View on SEC.gov ↗